PYYX · Pyxus International, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | $2.14B | $1.72B | $1.65B | $1.41B | - | $1.30B |
| Gross Profit | $342.98M | $312.33M | $261.02M | $227.06M | - | $224.68M |
| R&D | - | - | - | - | - | - |
| SG&A | $171.00M | $160.91M | $151.53M | $142.02M | - | $199.02M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $20.33M | $19.25M | $19.14M | $16.68M | - | $35.83M |
| Operating Income | $153.32M | $137.19M | $93.78M | $41.72M | - | ($11.61M) |
| Interest Expense | - | - | - | - | - | $136.66M |
| Income Tax | $25.05M | $27.28M | $34.13M | $12.64M | - | $131.79M |
| Net Income | $15.17M | $2.66M | ($39.14M) | ($82.12M) | ($270.32M) | ($264.66M) |
| EPS - Basic | $0.59 | $0.11 | ($1.57) | ($3.28) | - | ($28.93) |
| EPS - Diluted | $0.59 | $0.11 | ($1.57) | ($3.28) | - | ($28.93) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $85.54M | $99.79M | $138.91M | $93.14M | $97.71M | $173.08M |
| Accounts Receivable | $189.24M | $168.76M | $185.35M | $152.31M | $175.91M | $226.74M |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $132.87M | $181.25M | $170.29M | $59.17M | $103.50M | $67.09M |
| Current Assets | $1.16B | $1.31B | $1.22B | $1.33B | $1.12B | $1.23B |
| Total Assets | $1.50B | $1.66B | $1.58B | $1.70B | $1.54B | $1.76B |
| Current Liabilities | $773.95M | $905.16M | $715.06M | $669.02M | $601.73M | $789.07M |
| Long-term Debt | $454.85M | $497.73M | $618.43M | $512.33M | $551.24M | $904.32M |
| Total Liabilities | $1.34B | $1.51B | $1.44B | $1.52B | $1.29B | $1.84B |
| Stockholders' Equity | $160.09M | $142.28M | $137.85M | $175.28M | $247.67M | ($78.00M) |
| Retained Earnings | ($240.13M) | ($255.29M) | ($257.95M) | $0 | ($136.69M) | ($488.55M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($13.39M) | ($214.97M) | ($137.82M) | ($198.76M) | - | ($358.62M) |
| Investing Cash Flow | $170.64M | $159.45M | $154.94M | $181.24M | - | $181.35M |
| Financing Cash Flow | ($167.26M) | $25.56M | ($83.00M) | $123.26M | - | $159.88M |
| CapEx | $23.03M | $21.04M | $16.31M | $14.83M | - | $61.06M |
| Free Cash Flow | ($36.41M) | ($236.01M) | ($154.13M) | ($213.59M) | - | ($419.69M) |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | -2.40 | -88.63 | 3.94 | 2.60 | - | 1.59 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | 62.3% | 91.1% | - | - | - | - |
| Return on assets | 1.0% | 0.2% | -2.5% | -4.8% | -17.6% | -15.0% |
| Return on equity | 9.5% | 1.9% | -28.4% | -46.8% | -109.1% | 339.3% |
| Return on invested capital | 12.5% | 10.7% | 9.8% | 4.8% | - | -1.1% |
| Liquidity | ||||||
| Current ratio | 1.50 | 1.45 | 1.71 | 1.98 | 1.87 | 1.56 |
| Quick ratio | 1.50 | 1.45 | 1.71 | 1.98 | 1.87 | 1.56 |
| Cash ratio | 0.11 | 0.11 | 0.19 | 0.14 | 0.16 | 0.22 |
| Leverage | ||||||
| Debt / Equity | 2.84 | 3.50 | 4.49 | 2.92 | 2.23 | -11.59 |
| Debt / Assets | 0.30 | 0.30 | 0.39 | 0.30 | 0.36 | 0.51 |
| Debt / EBITDA | 2.62 | 3.18 | 5.48 | 8.77 | - | 37.34 |
| Interest coverage | - | - | - | - | - | -0.1x |
| Equity multiplier | 9.39 | 11.65 | 11.48 | 9.69 | 6.22 | -22.60 |
| Liabilities / Assets | 0.89 | 0.91 | 0.91 | 0.89 | 0.84 | 1.04 |
| Efficiency | ||||||
| Asset turnover | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | 23d | 38d | 38d | 15d | - | 19d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 6.0x | 25.0x | - | - | - | - |
| P / B | 0.6x | 0.5x | 0.2x | 0.2x | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | 2.6x | 3.0x | 4.5x | 7.8x | - | - |
| Growth | ||||||
| Revenue growth (YoY) | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - |
| Gross profit growth (YoY) | 9.8% | 19.7% | 15.0% | - | - | -10.4% |
| Operating income growth (YoY) | 11.8% | 46.3% | 124.8% | - | - | - |
| Net income growth (YoY) | 469.5% | - | 52.3% | 69.6% | -2.1% | -275.6% |
| EPS growth (YoY) | 436.4% | - | 52.1% | - | - | -271.9% |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 84.6% | -53.1% | 27.8% | - | - | -41.9% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 12.5% | 3.2% | -21.4% | -29.2% | - | - |
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
4/9
Neutral
- ✓Net income positive
- ✗Operating cash flow positive
- ✓ROA improved YoY
- ✗Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- -Gross margin improved
- -Asset turnover improved
Peer comparison
Same SIC group: Wholesale-Farm Product Raw Materials
Comparing PYXUS INTERNATIONAL against the 4 most active filers in the same SIC group.